13F HOLDINGS REPORT
Ghost Tree Capital, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001420506-23-001536
Total Value
$302.9M
Positions
57
Other Managers
0
Confidential Omitted
No
Holdings (57)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 300,000 | $25.0M | 8.24% |
| 2 | TG THERAPEUTICS INC | TGTX | 825,000 | $20.5M | 6.77% |
| 3 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 330,000 | $16.8M | 5.56% |
| 4 | AKERO THERAPEUTICS INC | 00973Y108 | 360,000 | $16.8M | 5.55% |
| 5 | APELLIS PHARMACEUTICALS INC | APLS | 180,000 | $16.4M | 5.41% |
| 6 | VAXCYTE INC | PCVX | 280,000 | $14.0M | 4.62% |
| 7 | REVANCE THERAPEUTICS INC | 761330109 | 525,000 | $13.3M | 4.39% |
| 8 | MADRIGAL PHARMACEUTICALS INC | MDGL | 55,000 | $12.7M | 4.19% |
| 9 | AMYLYX PHARMACEUTICALS INC | AMLX | 550,000 | $11.9M | 3.92% |
| 10 | VIKING THERAPEUTICS INC | VKTX | 650,000 | $10.5M | 3.48% |
| 11 | SAREPTA THERAPEUTICS INC | SRPT | 85,000 | $9.7M | 3.21% |
| 12 | ASCENDIS PHARMA A/S | ASND | 100,000 | $8.9M | 2.95% |
| 13 | REATA PHARMACEUTICALS INC | 75615P103 | 85,000 | $8.7M | 2.86% |
| 14 | AXSOME THERAPEUTICS INC | AXSM | 110,000 | $7.9M | 2.61% |
| 15 | SYNDAX PHARMACEUTICALS INC | SNDX | 350,000 | $7.3M | 2.42% |
| 16 | MIRATI THERAPEUTICS INC | 60468T105 | 200,000 | $7.2M | 2.39% |
| 17 | XENON PHARMACEUTICALS INC | XENE | 185,000 | $7.1M | 2.35% |
| 18 | COGENT BIOSCIENCES INC | COGT | 575,000 | $6.8M | 2.25% |
| 19 | PROTAGONIST THERAPEUTICS INC | PTGX | 225,000 | $6.2M | 2.05% |
| 20 | VIRIDIAN THERAPEUTICS INC | VRDN | 240,000 | $5.7M | 1.88% |
| 21 | BIOMEA FUSION INC | BMEA | 190,000 | $4.2M | 1.38% |
| 22 | INCYTE CORP | INCY | 65,000 | $4.0M | 1.34% |
| 23 | BEIGENE LTD | BEIGF | 22,500 | $4.0M | 1.32% |
| 24 | AMBRX BIOPHARMA INC | 02290A102 | 238,225 | $3.9M | 1.29% |
| 25 | VIR BIOTECHNOLOGY INC | VIR | 150,000 | $3.7M | 1.21% |
| 26 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 347,432 | $3.6M | 1.18% |
| 27 | AEROVATE THERAPEUTICS INC | 008064107 | 201,197 | $3.5M | 1.14% |
| 28 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 100,000 | $2.8M | 0.93% |
| 29 | KARUNA THERAPEUTICS INC | 48576A100 | 12,500 | $2.7M | 0.89% |
| 30 | TARSUS PHARMACEUTICALS INC | TARS | 150,000 | $2.7M | 0.89% |
| 31 | AMICUS THERAPEUTICS INC | FOLD | 200,000 | $2.5M | 0.83% |
| 32 | ASTRIA THERAPEUTICS INC | 04635X102 | 300,173 | $2.5M | 0.83% |
| 33 | UNIQURE NV | QURE | 215,000 | $2.5M | 0.81% |
| 34 | KRYSTAL BIOTECH INC | KRYS | 20,000 | $2.3M | 0.78% |
| 35 | VERONA PHARMA PLC | 925050106 | 110,000 | $2.3M | 0.77% |
| 36 | PHATHOM PHARMACEUTICALS INC | PHAT | 154,250 | $2.2M | 0.73% |
| 37 | FUSION PHARMACEUTICALS INC | 36118A100 | 412,699 | $1.9M | 0.64% |
| 38 | IMMUNOGEN INC | 45253H101 | 100,000 | $1.9M | 0.62% |
| 39 | PMV PHARMACEUTICALS INC | PMVP | 280,981 | $1.8M | 0.58% |
| 40 | AADI BIOSCIENCE INC | WHWK | 250,000 | $1.7M | 0.56% |
| 41 | ARCUS BIOSCIENCES INC | RCUS | 75,000 | $1.5M | 0.50% |
| 42 | ROCKET PHARMACEUTICALS INC | RCKTW | 75,000 | $1.5M | 0.49% |
| 43 | BIOCRYST PHARMACEUTICALS INC | BCRX | 200,000 | $1.4M | 0.46% |
| 44 | MORPHIC HLDG INC | 61775R105 | 20,000 | $1.1M | 0.38% |
| 45 | INHIBRX INC | INBX | 35,000 | $908,600 | 0.30% |
| 46 | BIOXCEL THERAPEUTICS INC | BTAI | 130,000 | $865,800 | 0.29% |
| 47 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 27,578 | $723,095 | 0.24% |
| 48 | BRIDGEBIO PHARMA INC | BBIO | 42,000 | $722,400 | 0.24% |
| 49 | AVIDITY BIOSCIENCES INC | 05370A108 | 65,000 | $720,850 | 0.24% |
| 50 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 100,000 | $704,000 | 0.23% |
| 51 | PTC THERAPEUTICS INC | PTCT | 16,675 | $678,172 | 0.22% |
| 52 | ROIVANT SCIENCES LTD | ROIV | 64,000 | $645,120 | 0.21% |
| 53 | RAIN ONCOLOGY INC | 75082Q105 | 325,000 | $390,000 | 0.13% |
| 54 | REPLIMUNE GROUP INC | REPL | 10,865 | $252,285 | 0.08% |
| 55 | VANDA PHARMACEUTICALS INC | VNDA | 31,000 | $204,290 | 0.07% |
| 56 | MERSANA THERAPEUTICS INC | 59045L106 | 61,250 | $201,513 | 0.07% |
| 57 | FIBROGEN INC | 31572Q808 | 36,500 | $98,550 | 0.03% |